Human neural stem cell (hNSC) derived exosomes vs CSC14 hNSCs for the treatment of traumatic brain injury (TBI)
Grant Award Details
Grant Number:
DISC2P-12150
Investigator(s):
Disease Focus:
Human Stem Cell Use:
Award Value:
$202,667
Status:
Active
Progress Reports
Reporting Period:
18 months
Reporting Period:
Post Project Allowable Costs
Grant Application Details
Application Title:
Human neural stem cell (hNSC) derived exosomes vs CSC14 hNSCs for the treatment of traumatic brain injury (TBI)
Publications
- Pain (2023): Biodegradable nanoparticles targeting circulating immune cells reduce central and peripheral sensitization to alleviate neuropathic pain following spinal cord injury. (PubMed: 37463227)
- J Neurotrauma (2021): Freshly Thawed Cryobanked Human Neural Stem Cells Engraft within Endogenous Neurogenic Niches and Restore Cognitive Function after Chronic Traumatic Brain Injury. (PubMed: 34130484)
- Res Sq (2023): Multichannel bridges and NSC synergize to enhance axon regeneration, myelination, synaptic reconnection, and recovery after SCI. (PubMed: 37502943)